Terug
29
Dagbereik
€ 493,24
€ 502,73
52-Weeksbereik
€ 465,59
€ 601,77
Volume
2.277.345
50D / 200D Gem.
€ 527,07
/
€ 556,85
Vorige Slotkoers
€ 500,38
Koershistorie
Financiële Trends
Sectorvergelijking
vs Financial Services sector mediaan (854 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 29,8 | 10,3 |
| P/B | 57,6 | 1,1 |
| ROE % | 210,5 | 11,6 |
| Net Margin % | 45,7 | 16,8 |
| Rev Growth 5Y % | 14,8 | 11,6 |
| D/E | 2,5 | 0,5 |
Koersdoel Analisten
Hold
€ 667,33
+33.8%
Low: € 610,00
High: € 739,00
Forward K/W
25,6
Forward WPA
€ 19,58
WPA Groei (sch.)
+0,0%
Omzet Sch.
37 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 34,13
€ 33,40 – € 34,87
|
57 B | 4 |
| FY2029 |
€ 29,70
€ 29,07 – € 30,34
|
52 B | 4 |
| FY2028 |
€ 26,33
€ 25,24 – € 27,08
|
47 B | 10 |
Insider Trading Activity
Buy ratio (90d)
50.0%
18 transactions
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 26, 2026 |
ABRAMS CAPITAL MANAGEMENT, L.P.
|
buy | 1.758.794 | € 7,00 | € 12.311.558 |
| Jan 13, 2026 |
Flagship Pioneering, LLC
|
grant | 4.470.936 | € 6,71 | — |
| Jan 5, 2026 |
North Run Strategic Opportunities Fund I, LP
|
buy | 3.499.289 | € 2,58 | € 9.028.166 |
| Jan 5, 2026 |
North Run Strategic Opportunities Fund I, LP
|
sell | 4.269.610 | € 11,72 | — |
| Jan 1, 2026 |
SUMMIT PARTNERS L P
|
buy | 354.189 | — | — |
| Jan 1, 2026 |
SUMMIT PARTNERS L P
|
other | 354.189 | — | — |
| Jan 1, 2026 |
SUMMIT PARTNERS L P
|
sell | 354.189 | — | — |
| Dec 31, 2025 |
North Run Strategic Opportunities Fund I, LP
|
sell | 1.860.465 | € 2,15 | € 4.000.000 |
| Nov 7, 2025 |
ADVENT INTERNATIONAL, L.P.
|
sell | 37.342.526 | € 7,76 | € 289.856.421 |
| Aug 26, 2025 |
THOMAS H. LEE ADVISORS, LLC
|
sell | 22.669.211 | — | — |
| Aug 21, 2025 |
DC VGA LLC
|
sell | 1.388.888 | € 14,41 | € 20.013.876 |
| Aug 7, 2025 |
ADVENT INTERNATIONAL, L.P.
|
sell | 30.000.000 | € 9,87 | € 296.145.000 |
| May 20, 2025 |
ADVENT INTERNATIONAL, L.P.
|
sell | 30.000.000 | € 9,08 | € 272.400.000 |
| May 19, 2025 |
Berkshire Partners LLC
|
sell | 17.290.465 | € 12,23 | — |
| May 19, 2025 |
Berkshire Partners LLC
|
buy | 7.290.465 | — | — |
| May 16, 2025 |
ABRAMS CAPITAL MANAGEMENT, L.P.
|
sell | 703.691 | € 80,91 | € 56.934.020 |
| May 15, 2025 |
ABRAMS CAPITAL MANAGEMENT, L.P.
|
sell | 4.673.986 | € 80,91 | € 378.161.457 |
| May 13, 2025 |
MPM BioVentures 2014, L.P.
|
sell | 630.191 | € 8,06 | € 5.079.339 |
Belangrijkste Punten
Revenue grew 14,79% annually over 5 years — strong growth
Earnings grew 16,27% over the past year
ROE of 210,49% indicates high profitability
Net margin of 45,65% shows strong profitability
Debt/Equity of 2,46 — high leverage
Generating 16,91B in free cash flow
Groei
Revenue Growth (5Y)
14,79%
Revenue (1Y)16,42%
Earnings (1Y)16,27%
FCF Growth (3Y)20,70%
Kwaliteit
Return on Equity
210,49%
ROIC54,42%
Net Margin45,65%
Op. Margin59,17%
Veiligheid
Debt / Equity
2,46
Current Ratio1,03
Interest Coverage26,87
Waardering
P/E Ratio
29,75
P/B Ratio57,55
EV/EBITDA23,36
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 16,42% | Revenue Growth (3Y) | 14,30% |
| Earnings Growth (1Y) | 16,27% | Earnings Growth (3Y) | 15,63% |
| Revenue Growth (5Y) | 14,79% | Earnings Growth (5Y) | 14,57% |
| Profitability | |||
| Revenue (TTM) | 32,79B | Net Income (TTM) | 14,97B |
| ROE | 210,49% | ROA | 27,64% |
| Gross Margin | 83,43% | Operating Margin | 59,17% |
| Net Margin | 45,65% | Free Cash Flow (TTM) | 16,91B |
| ROIC | 54,42% | FCF Growth (3Y) | 20,70% |
| Safety | |||
| Debt / Equity | 2,46 | Current Ratio | 1,03 |
| Interest Coverage | 26,87 | Dividend Yield | 0,01% |
| Valuation | |||
| P/E Ratio | 29,75 | P/B Ratio | 57,55 |
| P/S Ratio | 13,58 | PEG Ratio | 1,81 |
| EV/EBITDA | 23,36 | Dividend Yield | 0,01% |
| Market Cap | 445,26B | Enterprise Value | 453,14B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 32,79B | 28,17B | 25,10B | 22,24B | 18,88B |
| Net Income | 14,97B | 12,87B | 11,20B | 9,93B | 8,69B |
| EPS (Diluted) | 16,52 | 13,89 | 11,83 | 10,23 | 8,76 |
| Gross Profit | 27,36B | 21,49B | 19,08B | 16,97B | 14,40B |
| Operating Income | 19,40B | 15,58B | 14,01B | 12,26B | 10,08B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 54,16B | 48,08B | 42,45B | 38,72B | 37,67B |
| Total Liabilities | 46,41B | 41,57B | 35,45B | 32,35B | 30,26B |
| Shareholders' Equity | 7,74B | 6,49B | 6,93B | 6,30B | 7,31B |
| Total Debt | 19,00B | 18,23B | 15,68B | 14,02B | 13,90B |
| Cash & Equivalents | 11,13B | 8,44B | 8,59B | 7,01B | 7,42B |
| Current Assets | 23,56B | 19,72B | 18,96B | 16,61B | 16,95B |
| Current Liabilities | 22,76B | 19,22B | 16,26B | 14,17B | 13,16B |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#139 of 157
Recente Activiteit
Ingestapt
Growth Investing (Philip Fisher)
Mar 24, 2026